As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies
The Institute of Human Biology (IHB) enables scientists to pioneer human model systems, accelerating the development of new medicines to improve the lives of patients
Investment demonstrates confidence in America’s commitment to science and innovation
Biocon Foundation has been steadfast in its mission to empower underserved communities through innovative healthcare solutions, education, and sustainable development initiatives
Acquisition will advance Merck’s integrated offering for viral vector manufacturing
Dr. Grant brings to the table significant BOD governance, global business development, and corporate development expertise
This facility will design & develop instruments, perform product reliability performance testing and verification
Cedars-Sinai Medical Center Surgeon and Surgical Innovation Officer Dr. Jain joins the venture fund to bring clinical expertise to a portfolio of budding seed-stage healthcare companies
Daewoong Pharmaceutical, HanAll Biopharma join Astellas Venture Management and other VCs in oversubscribed funding round to accelerate Turn Bio's preclinical advances in multiple therapeutic areas
The fund has already invested in seven companies including Medikabazaar, THB, Impact Guru, Stanplus, Ekincare, Qure.ai and HealthifyMe
Subscribe To Our Newsletter & Stay Updated
